In coordination with the Mt. Sinai Health System and the U.S. Department of Health and Human Services (HHS), the American Society of Nephrology (ASN) hosted a town hall for KidneyX on Tuesday, June 26 in New York, NY.
The town hall convened a diverse, multi-stakeholder group to better understand how KidneyX can meet the needs of patients and encourage providers, innovators, and researchers to participate.
The town hall brought together HHS leaders from the Office of the Chief Technology Officer, the National Institutes of Health, the Food and Drug Administration and the Centers for Medicare and Medicaid Services,
as well as patients, providers, startups, and the biopharmaceutical and venture capitalist communities.
The discussion focused on how KidneyX will aim to accelerate innovation in the diagnosis, prevention and treatment of kidney diseases, partnership ideas and perspectives on barriers and opportunities for participation.
Specifically, input was elicited from:
Patients about what new developments in kidney products they most want and value;
Startups in the kidney space about how KidneyX could best help them move from concept to product in patients' hands (financial, regulatory, business insights, etc.);
Academic institutions about how their research efforts, faculty, students, and trainees can foster the success of KidneyX and potentially partner, as well as interface with patients receiving treatment in their facilities;
Investors about what guides and influences their investment decisions, specifically in the kidney space